EUVIMEDEUVIMED entdecken
Crossref

Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study

Katsuyuki Takahashi, Minami Abe, Hirotake Yamase, Hideki Yoshino, Kayo Tsujii, Yuika Komatsu, Toru Otori, Masahiko Kobayashi

Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 526-536

DOI: 10.5414/cp204997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Katsuyuki Takahashi und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Oligopeptides, Hydrazines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsOligopeptidesHydrazinesReceptors, GhrelinHumansRetrospective StudiesFemaleMaleMiddle AgedAgedTreatment OutcomeMultivariate AnalysisTime FactorsNutritional StatusLogistic ModelsNutrition AssessmentRisk FactorsAged, 80 and over

Substanzen

anamorelinOligopeptidesHydrazinesReceptors, Ghrelin

Zitieren

APA

Takahashi, K., Abe, M., Yamase, H., Yoshino, H., Tsujii, K., Komatsu, Y., Otori, T., & Kobayashi, M. (2026). Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 526-536. https://doi.org/10.5414/cp204997

Vancouver

Takahashi K, Abe M, Yamase H, Yoshino H, Tsujii K, Komatsu Y, et al. Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):526-536. doi:10.5414/cp204997

BibTeX
@article{Takahashi2026,
  author = {Takahashi, Katsuyuki and Abe, Minami and Yamase, Hirotake and Yoshino, Hideki and Tsujii, Kayo and Komatsu, Yuika and Otori, Toru and Kobayashi, Masahiko},
  title = {Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {10},
  pages = {526--536},
  doi = {10.5414/cp204997}
}
Kostenlos starten →